GPS2 and metabolic disease: Because GPS2 expression, and thereby corepressor complex function, in tissue macrophages is altered in immuno-metabolic disease contexts in humans (20,36), our study should stimulate the further investigation of IL4 signaling in human macrophage subtypes.